香港股市 將在 3 小時 8 分鐘 開市

健倍苗苗 (2161.HK)

HKSE - HKSE 延遲價格。貨幣為 HKD。
加入追蹤清單
1.310-0.090 (-6.43%)
收市價: 3:59PM HKT

健倍苗苗

Unit 2303-07, Tower 1
23rd Floor, Millennium City 1 388 Kwun Tong Road
Kwun Tong
Hong Kong
852 2267 2178
http://www.jbmhealthcare.com.hk

版塊Healthcare
行業Pharmaceutical Retailers
全職員工

高階主管

名稱標題支付行使價出生年份
Mr. Yat Wai WongCEO & Exec. Director1964
Mr. Kau Lap LamGroup Financial Controller1987
Ms. Man Yee AuCOO & Company Sec.1973
Ms. Chui Yee LoSr. Marketing Mang.1969
Dr. Ka Wing ChuExec. Director & Pres of the Proprietary Chinese Medicine Bus.1973
截止 為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 HKD。

描述

JBM (Healthcare) Limited develops, manufactures, distributes, and markets healthcare and wellness products in Asia. It offers consumer healthcare and proprietary Chinese medicines, such as over-the-counter medicines, and medicated and non-medicated solutions, as well as diagnostic devices. The company was incorporated in 2020 and is headquartered in Kwun Tong, Hong Kong. JBM (Healthcare) Limited operates as a subsidiary of JBM Group (BVI) Limited.

公司管治

截至 無 止,健倍苗苗 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中:無;董事會:無;股東權利:無;現金賠償:無。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。